-
Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance
Joosten, S. P. J., Spaargaren, M., Clevers, H. & Pals, S. T., 1 Dec 2020, In: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1874, 2, 188437.Research output: Contribution to journal › Review article* › Academic › peer-review
-
MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance
Joosten, S. P. J., Mizutani, T., Spaargaren, M., Clevers, H. & Pals, S. T., 2019, In: Gastroenterology. 157, 4, p. 1153-1155.e1Research output: Contribution to journal › Article* › Academic › peer-review
-
Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins
van Andel, H., Ren, Z., Koopmans, I., Joosten, S. P. J., Kocemba, K. A., de Lau, W., Kersten, M. J., de Bruin, A. M., Guikema, J. E. J., Clevers, H., Spaargaren, M. & Pals, S. T., 2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 2, p. 376-381Research output: Contribution to journal › Article* › Academic › peer-review
- All publications